Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.
about
Increased severity of urinary tract infection and bacteremia in mice with urinary bladder injury induced by cyclophosphamideSimple and microbiologically safe portable transport unit for patients requiring protected isolation.Preventing infection in neutropenic cancer patients.In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patientsAcute cytomegalovirus infections in leukemic mice.Nononcologic disease in patients with cancerR-factor inheritance and plasmid content in mucoid Pseudomonas aeruginosa.Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycinFeasibility of administering aminoglycoside antibiotics by continuous intravenous infusion.Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine.Virus infections in children with acute lymphoblastic leukaemia.Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.Neutrophil chemotaxis and random migration in acute lymphoblastic leukaemia of childhood. Cellular and humoral aspectsEmpirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.Septicemia in children with leukemiaClinical efficacy of cefotaxime in serious infections.Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitroPirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.Infection in acute leukemia patients receiving oral nonabsorable antibioticsComparison of serum bactericidal activity among three antimicrobial combinations.Laboratory diagnosis and clinical significance of rubella in children with cancer.Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents.Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patientsQuantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis.Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitroInhibitory effect of Pseudomonas aeruginosa on phagocytosis and killing of rabbit polymorphonuclear leukocytes.The use of plastic isolators to prevent infection in neutropenic patients.Blind therapy in emergencies.Letter: Granulocyte transfusions.Atypical measles infections in leukaemic children on immunosuppressive treatment.Occult pulmonary haemorrhage in leukaemia.
P2860
Q28367923-D2992DE9-2C05-4581-A90E-CD5E52E257FEQ30502877-C6B9E84C-069C-42E7-AF01-4285418616C6Q33580542-90CB888F-6EA8-4845-AC40-6E5AD7D71C24Q33729054-5C9FCB57-4826-4362-90BF-4BC5DDC2B407Q33905725-94934BDD-371C-4366-925F-44FD62CA9792Q34051018-66334FD7-9137-4CEC-966B-B0F981595CA5Q34460990-43771F6A-AED0-4A69-852A-E5096E363EA0Q34928940-EE5BDE97-0AD3-4803-8A0C-CBDF4FD4B04FQ34942199-FDD6DE34-83DD-435C-B7AB-D3763D5193E7Q34982841-1C1ECE91-CCA0-444C-90A5-6C9B4FE340F2Q34988046-95C3E613-ADD4-4E2C-B166-6358F48F2323Q34988048-61C0560F-6901-4BD2-AE39-D87AF7BCFC7BQ34988087-5C2F3AF8-D9F2-4860-8A5D-727CC906E0DFQ35114224-ADC0B602-772B-458B-A21D-957341122B45Q35540674-E93DF3A7-C883-487B-84EF-3FCDA2DEF21DQ35672859-5C153251-8B46-4E11-9099-B6A255749E0FQ35673235-8BBB569B-50C6-44A5-9C3B-8ED2E18B03E0Q36335435-6550DFD1-F138-4C9D-8451-ABFE29A90AC1Q36460617-0A9E1AA0-6EB8-44DA-B6EB-3FCBF5F670C8Q36470777-C3008B22-754F-4CDD-A0F6-BD6EEF354B78Q36471007-A0409CD2-03F5-4388-9E2B-8B3FC7F6F66BQ36473408-37A127D8-0DF2-4251-A279-8587582590AAQ36475674-1694979D-59CF-4FD2-9060-D845E9ED401DQ36479359-DE513D4F-059C-447C-A2AF-EDAE824DB0B0Q37329610-B89209ED-19EB-4B62-A267-38EFFB49F809Q40944742-C10E1468-CDA8-4A0B-9CA6-514C185AB91DQ41171292-2847EE56-0B97-4AA5-909A-EEC6BDCE1565Q41223009-EB5A57C9-A864-42BC-A736-9905A68569BCQ42096983-35C6D95F-D773-418E-A527-89EC9AB25A0EQ42126884-B61187A5-7C6F-45D8-B9EC-11AADE4D3B7EQ48381102-4194E98A-6D59-4A4A-B079-D0A8D126EEC0Q55034637-5C6BDFB5-C635-4CCC-9C44-802BC19FC5BE
P2860
Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Hematologic malignancies and o ...... nt of complicating infections.
@en
Hematologic malignancies and o ...... nt of complicating infections.
@nl
type
label
Hematologic malignancies and o ...... nt of complicating infections.
@en
Hematologic malignancies and o ...... nt of complicating infections.
@nl
prefLabel
Hematologic malignancies and o ...... nt of complicating infections.
@en
Hematologic malignancies and o ...... nt of complicating infections.
@nl
P2093
P1476
Hematologic malignancies and o ...... ent of complicating infections
@en
P2093
P304
P577
1974-04-01T00:00:00Z